Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
0 mg, orlistat, phenterminetopiramate, and naltrexonebupropion for weight loss efficacy Semaglutide exerts its pharmacological activity by high-affinity, selective activation of the GLP-1 receptor on pancreatic ?-cells, ?-cells, and key appetite-regulating neuronal circuits: Pharmacokinetic Profile Route of Administration SC Dosing Frequency Once weekly Half-Life 184 hours Pharmacokinetic Profile: Route of Administration : Subcutaneous Dosing Frequency : Once weekly (subcutaneous) Half-Life : ~155184 hours (6.57.7 days), supporting once-weekly SC dosing Formulation : Formulation & Handling Reconstitute in sterile water or PBS (pH ~7.4) for in vivo/in vitro use Store at 20C in aliquots to prevent freeze-thaw degradation Shelf-stable for 12 months under recommended storage condition Clinical Trial Activity Clinical Trial Activity (Selected) References Quality & Purity This product is synthesized via solid-phase peptide synthesis (SPPS) and tested to 99% purity by HPLC with identity confirmed by mass spectrometry
Insulin Regulation, Blood Glucose Stability, and Energy Levels Beyond the stomach, the medication acts on the pancreas to optimize how your body handles sugar
Medical history The couple had been attempting conception for seven years without success, and the etiology of their infertility remains undetermined
Prazma J, Carrasco VN, Butler B, Waters G, Anderson T, Pillsbury HC
S., & Harrison, A
